CELLKINE: A PHASE I STUDY EVALUATING THE SAFETY AND FEASIBILITY OF ALLOGENEIC, CULTURE-EXPANDED BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN SUBJECTS WITH PAINFUL LUMBAR FACET JOINT ARTHROPATHIES

被引:0
|
作者
Yan, D. [2 ]
Zubair, A. [1 ,3 ]
Osborne, M. [2 ]
Wang, Z. [4 ,7 ]
Kubrova, E. [6 ]
Rosado, R. Pagan [6 ]
Diehn, F. [5 ]
Lehman, V. [5 ]
Durand, N. [1 ,3 ]
Quinones-Hinojosa, A. [8 ,9 ]
Qu, W. [2 ,3 ]
机构
[1] Mayo Clin Florida, Lab Med & Pathol, Jacksonville, FL USA
[2] Mayo Clin Florida, Pain Med, Jacksonville, FL USA
[3] Mayo Clin Florida, Ctr Regenerat Biotheraput, Jacksonville, FL USA
[4] Mayo Clin Minnesota, Robert & Patricia Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA
[5] Mayo Clin Minnesota, Radiol, Rochester, MN USA
[6] Mayo Clin Minnesota, Phys Med & Rehabil, Rochester, MN USA
[7] Mayo Clin Minnesota, Evidence Based Pract Ctr, Rochester, MN USA
[8] Mayo Clin Florida, Neurosurg, Jacksonville, FL USA
[9] Mayo Clin Florida, Canc Biol, Jacksonville, FL USA
关键词
Bone Marrow-Derived Mesenchymal Stem Cells; Lumbar Facet Joint Arthropathy; Phase I trial;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
196
引用
收藏
页码:S82 / S83
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint
    Pawan Kumar Gupta
    Anoop Chullikana
    Mathiyazhagan Rengasamy
    Naresh Shetty
    Vivek Pandey
    Vikas Agarwal
    Shrikant Yeshwant Wagh
    Prasanth Kulapurathu Vellotare
    Devi Damodaran
    Pachaiyappan Viswanathan
    Charan Thej
    Sudha Balasubramanian
    Anish Sen Majumdar
    Arthritis Research & Therapy, 18
  • [42] Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy
    Chung, Seok Jong
    Lee, Tae Yong
    Lee, Yang Hyun
    Baik, KyoungWon
    Jung, Jin Ho
    Yoo, Han Soo
    Shim, Chang Jae
    Eom, Hyojin
    Hong, Ji-Yeon
    Kim, Dong Joon
    Sohn, Young H.
    Lee, Phil Hyu
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [43] Comments on: "A Phase IB/IIA Study of Ex Vivo Expanded Allogeneic Bone-Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease"
    Cheng, Fang
    DISEASES OF THE COLON & RECTUM, 2024, 67 (03) : E202 - E202
  • [44] Comment on "A phase IB/IIA study of ex vivo expanded allogeneic bone-marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn disease. "
    Cheng, Fang
    SURGERY, 2024, 175 (05) : 1463 - 1464
  • [45] Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study
    Reinders, Marlies E. J.
    de Fijter, Johan W.
    Roelofs, Helene
    Bajema, Ingeborg M.
    de Vries, Dorottya K.
    Schaapherder, Alexander F.
    Claas, Frans H. J.
    van Miert, Paula P. M. C.
    Roelen, Dave L.
    van Kooten, Cees
    Fibbe, Willem E.
    Rabelink, Ton J.
    STEM CELLS TRANSLATIONAL MEDICINE, 2013, 2 (02) : 107 - 111
  • [46] Safety and efficacy of intracoronary artery administration of human bone marrow-derived mesenchymal stem cells in STEMI of Lee-Sung pigs-A preclinical study for supporting the feasibility of the OmniMSC-AMI phase I clinical trial
    Chen, Wannhsin
    Hou, Chun-Hsiang
    Chen, Yi-Ling
    Shen, Hsin-Hsin
    Lin, Chen-Hsuan
    Wu, Cheng-Yi
    Lin, Meng-Hsueh
    Liao, Chih-Ching
    Huang, Jun-Jae
    Yang, Chi-Yu
    Li, Yi-Chen
    Yip, Hon-Kan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [47] Safety and Efficacy of Transplantation of High Cumulative Dose Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Idiopathic Pulmonary Fibrosis and Rapid Lung Function Decline
    Averyanov, A.
    Koroleva, I.
    Sotnikova, A.
    Konoplyannikov, M.
    Lesnyak, V.
    Danilevskaya, O.
    Baklaushev, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
    Pawan K Gupta
    Anoop Chullikana
    Rajiv Parakh
    Sanjay Desai
    Anjan Das
    Sanjay Gottipamula
    Sagar Krishnamurthy
    Naveen Anthony
    Arun Pherwani
    Anish S Majumdar
    Journal of Translational Medicine, 11
  • [49] A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
    Gupta, Pawan K.
    Chullikana, Anoop
    Parakh, Rajiv
    Desai, Sanjay
    Das, Anjan
    Gottipamula, Sanjay
    Krishnamurthy, Sagar
    Anthony, Naveen
    Pherwani, Arun
    Majumdar, Anish S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [50] Co-transplantation of haplo-identical bone marrow-derived mesenchymal stem cells and hematopoietic stem cells to promote engraftment in children.: A phase I/II multicenter study.
    Ball, L. M.
    LeBlanc, K.
    Roelofs, H.
    Lankester, A. C.
    Egeler, M.
    Frassoni, F.
    Ringden, O.
    Fibbe, W. E.
    CYTOTHERAPY, 2006, 8